In short
Podcast Summary: CNBC's "Fast Money" - Inflection Point For The Market… And the JPMorgan Healthcare Conference Kicks Off (01/13/25)
Episode Overview In this episode of Fast Money, hosted by Melissa Lee along with a panel of top traders, the discussion centers around significant fluctuations in the stock market, particularly popular names like Nvidia, Tesla, and Bitcoin, and the upcoming earnings season for banks. The episode also highlights essential insights from the JPMorgan Healthcare Conference, focusing on the health care industry's latest developments.
Key Topics and Discussions
Market Movements
- Recent Trends: Several high-profile stocks have experienced notable declines.
- Apple: Ended down 1%, over $25 off its Christmas high.
- Nvidia, Bitcoin, and Tesla: All reported double-digit percentage drops.
- Economic Indicators: The 10-year Treasury yield hit a 14-month high.
- Dollar Index: Reached its highest level in over two years.
- Earnings Season: A significant number of earnings reports are expected from major financial institutions (e.g., JPMorgan, Goldman Sachs, Wells Fargo).
Market Sentiment
- Optimism vs Pessimism:
- Optimists: Reflect on a solid market rebound and a positive reversal off lows.
- Pessimists: Warn of a fragile bounce amid rising yields and economic challenges.
- Discussion on Yields:
- The panel expressed concern regarding the sustainability of rising yields and their potential impact on the equity market.
Healthcare Insights
- JPMorgan Healthcare Conference:
- Focused on the obesity drug market and potential deal-making opportunities.
- Observations from top executives on the future landscape of the healthcare sector.
Stock-Specific Insights
- KB Home: Reported strong earnings, with net new orders up by 40% year-over-year, despite high mortgage rates.
- Howard Hughes: Bill Ackman’s bid to take the company private is highlighted as a significant move in the real estate sector.
Expert Opinions
- Julian Emanuel from Evercore ISI:
- Projects potential market testing around 5,700 with a bullish outlook for the end of the year at 6,800, provided the 10-year yield remains under control.
- Concerns on Inflation:
- Discussed the impact of rising commodity prices and its implications for consumer behavior and spending.
Key Takeaways
- Market Condition: The current market is exhibiting signs of volatility, with traders weighing the implications of rising treasury yields and the upcoming earnings season.
- Healthcare Innovations: The ongoing developments in the obesity treatment space may lead to significant partnerships and market shifts.
- Investor Sentiment: There is a mixed sentiment among investors, with some traders remaining optimistic about future earnings while others express caution due to economic indicators.
Conclusion The episode encapsulates a pivotal moment for the stock market, characterized by significant stock movements, upcoming earnings reports, and discussions on macroeconomic factors influencing investor sentiment. The traders provide a nuanced perspective on navigating these complexities, particularly in the face of rising yields and changing dynamics in the healthcare sector.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:02Live from the Nasdaq market site in the heart of New York City's Times Square this is fast money. Here's what's on tap tonight. Pause or pullback? Some of last year's hottest trades dropping sharply from recent records. Is this just a rally taking a breather or a sign of more trouble ahead? And weighty issues, the obesity drug space front and center at this year's J.P. Morgan Health Care Conference. The latest from the top players in the space and what we might be hearing about potential deal making. Plus, KB Holman's solid foundation after earnings. Our pair of rivals teaming up to buy U.S. steel and why hedge fund titan Bill Ashton is looking to take over Howard Hughes.
0:35I'm Melissa Lee coming to you live from Studio B at the NASDAQ. On the desk tonight, Tim Seymour, Karen Feinerman, Dan Nathan, and Guy Adami. We start off with the major moves in some of the market's most popular names. Apple spending most of the day in correction territory, ending down a percent, and now more than$25 off its post-Christmas high. NVIDIA, Bitcoin, and Tesla down double-digit percentages, all as a 10-year Treasury yield hits a 14-month high after last month's blowout jobs report, last week's, I should say, and has chances of a rate cut this month lessen. The dollar index also on the move at its highest in over two years.
1:08And don't look now, but a huge slate of earnings is upon us. J.P. Morgan, Goldman Sachs, Wells Fargo, and Citi kick things off for the big banks on Wednesday, followed by reports from Taiwan Semi, UnitedHealth, and many more later this week. So is this just a temporary pause on the road higher for stocks, or are we nearing a major inflection point for this market, Guy? That's an interesting setup, Melm. So here you go. I'll give you my sort of two cents. An optimist will say, you know what? Great reversal today off the lows. That was very impressive. The VIX backed off. Great day. We're going higher now from here.
1:42Pessimists will say that's a pretty feeble bounce. Is that what you said? Well, I tend to be pessimistic. Well, you know where I stand. I'm not trying to bury anything here. Off what was a pretty miserable day on Friday. I'll say this. I think right now as we're sitting here, 10-year yields are now firmly above 480. I think they're trading 481 or so. That's the story. So the market in this environment, our economy and our stock market is not set up to have yields trade higher in the manner they have over the last couple months. Which camp are you in, Karen? I'm not a pessimist. You know, I'm always long, so you have to kind of always be optimistic.
2:17I am concerned about the rate thing. But remember, I mean, we are off a good at least 5 % since that December peak, whenever that was. So, you know, we'll see. I like to, you know, know what earnings are and understand what are the fundamentals. And so I also really like to hear from banks because not only do we get their fundamentals, but they have such a good look on the economy at large. And I think we're going to see some good earnings. So I am long staying long. So intraday at one point, the S &P was below the 50 day moving average, and it hadn't been there since August 4th, 5th, essentially when we had a growth scare.
2:52So we don't we have the opposite of that here. We have we have a bit of a rate scare. And the question, as we always ask, is this move orderly? And I think 120 basis points in the 10-year from almost the moment the Fed started hiking rates is reasonably orderly. What's happening in Japan doesn't feel very orderly. And I think if you look around the world, there's some places where those bond markets aren't acting orderly at all. And I think there's an issuance glut that's coming. And I think we're seeing it in other parts of the world as much. And in terms of the administration coming in, we know there's a growth first, debt second kind of approach here.
3:24So back to equities, it's a very interesting day because that reversal is very important. It's not just the S &P, but semiconductors. If you look at the SMH, it was clinging to that 200. It's been kind of bouncing along there, finished positively. But again, getting back to the leadership of whether you do have the MAG7 and the outperformance of a couple to each other is also very interesting. Meta up almost 11 percent to Apple year to date. But I think equities came into this year with uber complacency, cash levels uber low, no expectation that the job market was going to be quite this strong.
3:58And I think it's a reaction. And I think that's something volatility will come with that. But my glass is half full. Yeah, I'm pretty neutral right here. And I'm in Karen's camp. I want to wait for Q4 earnings. And really, more importantly, I guess, Q1 guidance, if there's anything we can glean into the year. You know, expectations for earnings growth are still 12%, 13 % or so. And I just don't know how you get there for these large multinationals who are dealing with a dollar that's trading at multi-year highs. You have yields that are trading very near multi-year highs, you know. And I'm just looking at like crude oil.
4:29You know, today you saw the airlines. They were all down like four some percent. I'm looking at what's the headlines. We saw some earnings last week. It was crude oil trading at 79 bucks is what I suspect here. So when I think about this, it's got to come from the leadership, that fateful aid. If you look at some of those names that we saw today, you're talking about, you know, a big reversal in Tesla. Apple did stay down in the day. It had a fundamental reason to stay down in the day. So when I think about what happened, there was a lot of pull forward over the last kind of month and a half or so.
4:57So now we have to wait for earnings. We have to wait for this inauguration because one of the things I think is really important is, like, some of these big moves that we saw after November 6th, right? So you had these kind of runaway FOMO sort of trades. Well, they've given a lot of it back, right? So it was expectations of maybe a different regulatory environment. Now we get to the confirmation phase of all these folks that are going to be, you know, that were nominated for these roles. And I think this is the back and forth that you get on policy. And this might shift sectors. We've had a really nice run.
5:26Some of them have given a lot of that back. So I think earnings and I think, you know, the confirmation period is going to be really important for regulation. You mentioned your fateful eight, and that brings into light the fateful eight being the biggest seven stocks. Yeah, formerly the MAG seven plus Broadcom. But just in case people haven't really cracked the term. We're getting comfortable with that here. It's not an acronym. No. Stay tuned. We need to clarify. Maybe for you, Karen. Stay tuned. I was going to say, it didn't work. It's good enough. Not for Dan. But that sort of underscores just how this market is built, and the market is built on the market cap of these stocks.
5:59And you mentioned Apple being down for a fundamental reason. NVIDIA was down for another fundamental reason, the fear of further export control. I mean, there are certain things that some of the biggest stocks are actually grappling with. And it's not just positioning here. It's actual fundamental issues which might affect their business. Yeah, each have their own without question. And I think we're at a point now where 10 stocks, so 2 % of the S &P 500 are 40 % of the weighting of the S &P 500, which is remarkable. I've got to believe that's some sort of record. But, you know, it speaks to the top heaviness of the market.
6:31And maybe it's not as broad-based rally as we thought. But with your point is well taken. Each of these names have their own issues. The one that I think is interesting, they're all interesting, but, you know, the move in Apple seemingly come out of nowhere. Yeah, there have been some negative headlines along the way, but we've seen that before. And the stock didn't seem to care for every reason it is now. But, you know, I encourage you to go back. Look at where we topped out in July all through the summer into October. It was sort of 232 or so. That was a prior all-time high. That should be support.
7:00And that's where we seemingly are stopping right now on the downside. It feels like it's become in vogue to criticize Apple and to say iPhone sales are going to be soft. And iPhone, there's no reason to upgrade the phone. People are going to last longer. People don't want a future proof. Their purchase of an iPhone, you know, buying an advanced version in anticipation of those AI sort of features, because Apple hasn't shown any proof of those AI features at this point. At some point, this becomes consensus, though. That's fine. It's not in the stock. I mean, you can't tell me the stocks. The stocks, first of all, now that it's given back some of this move, The stock's effectively up 10 % in two and a half years in one of the greatest bull markets of all time.
7:36There's nothing in Apple stock. This is one of the best stocks in the market in terms of giving back capital, in terms of running their business as a cash flow machine. The services business isn't 30 % plus, but it's certainly solidly 20s, and it's certainly got a margin attached to it that allows it to trade at a higher number. Should it trade at 33 times forward? Probably not. But I just go back to Apple and I say this is a company that I feel really comfortable owning in this environment relative to some of its peers in that. Faithful 8. Faithful 8. Faithful. So, I mean, I think you've got a dynamic here where it really is.
8:09I would take all that negativity and say that's right and it's in the price. I would say if you're looking for Faithful 8 that are really, I think, value. To me, meta and alphabet are far more compelling and multiples much closer to a market multiple than 32 odd, whatever it is. Was that a movie with like Denzel where they think that a remake? I don't know. It was the hateful. Oh, the hateful. Oh, so you're playing on words. Is it Denzel or Denzel? There's a lot of stuff going on. The fact that we have to explain this and spend that much time. Well, by the way, Denzel is a huge fan of Fast Money.
8:43He's watching right now. So we're all the eight. We're not spending a lot of time talking about Amazon, which I think is really interesting because there's a lot of levers to pull. We think about some of the stuff we came in today. We saw Lulu guide up. They're kind of saying some pretty decent things about holiday sales. We know that obviously that's not a huge margin contribution there. But some of the stuff out of AWS over the last year and a half or so coming off of a bottom, I think that's one to really keep an eye on. But I also agree with Karen on the alphabet. I mean, this is one that's been fairly underappreciated.
9:12I think the underappreciation as it relates to Microsoft probably has more to do with this kind of early leap that they had as far as their relationship with OpenAI. But also when you think about this company, they're not getting a lot of uptake with the co-pilots, which is what this OpenAI technology was powering. All right. Well, Evercore ISI bracing for further market weakness. Julian Emanuel is the firm's senior managing director. He joins us here on set. Julian, great to see you. Great to be here. How much more weakness are you thinking of? Probably not a lot more. OK, so we came in essentially December the 18th.
9:46The FOMC changed the outlook on how to think about volatility. And we finally get this this idea where, yes, there's damage being done by virtue of higher yields. And yes, at what was then 25 times trailing earnings, markets are going to be vulnerable to less than perfect news. And we've had a lot of less than perfect news over the last several weeks. But when we think of the manic swings in sentiment we've seen in just, frankly, since the beginning of the year, and you superimpose that on the fact that earnings season is starting Wednesday, you're going to get a CPI report on Wednesday, and you're going to get a new president inaugurated on Monday.
10:28Even if some of the information there is less than perfect for markets, you're going to have resolution of uncertainty to a certain degree. So to us, we think you possibly test 5 ,700 on the downside. If things get, you know, incrementally more ugly, maybe down to 5520. But for us, the bigger picture is we think you're going to 6 ,800 by the end of the year. So thanks for being here. So if you were to get to that 6 ,800, what do you think are what makes up that perfect environment in terms of unemployment, inflation, capital, I mean, financial conditions. What's the perfect brew there? The most important thing is that the 10-year yield remains in check.
11:16What's check? OK, check is basically called 450. You could nudge towards 5%. But frankly, if you look at this, the entirety of this bull market going back to October of 2022, stocks have had difficulty as they are now when you get above 475. And you've actually only spent one day at 5 percent in that entire time. And that was the end of the biggest correction that we've had this entire cycle. So to us, that is the thing, because the Fed, I don't care what anyone says, the Fed's not hiking rates this year. Let's put that aside. And we don't think there's a recession. But what you're left is how effective the bond vigilantes are going to be in dictating what the limits of policy and dictating where multiples can go.
12:06Are you worried, although, about inflation as it relates to me? Look at copper prices going higher here. Look at oil prices going higher. I realize there's been fundamental news around the oil market. I don't think so much around copper. What we're seeing feed through here, look, a lot of people, the Fed funds rate means nothing to what they pay for their mortgage, for their houses, corporate borrowing. I mean, I think inflation is going higher. And I think leaving the Fed aside, how does that play into the equity market? So, look, over the long term, inflation in manageable dollops tends to be positive for equities.
12:39We know that's one of the rationales. I think you have to think about it within the context of what the intent is this year. And when you look at the Fed, they're likely going to tolerate inflation being a little bit stickier. the same way they did last year in the spring, simply because their read right now is that the longer term 10 year yield moving up the way it has is likely going to moderate financial conditions from overheating. After being inverted for the longest time in history, the yield curve is now as steep as it's been probably in four or five years ish. Good or bad? Net good. OK, I think this entire cycle going back to post pandemic, the return of, quote, unquote, normal price of money and normal term premiums.
13:31We both know that in our careers, this is still very low in terms of where the yield curve is. And you could go a lot higher. Our concern is that it happens in a more disorderly way if there's a reaction to policy as it evolves over the next several months. But we don't expect that as our base case. Julian, great to see you. Thank you for stopping by. Thank you. Julian Emanuel. So, Steve, that's good for banks. We're going to hear from them. I mean, J.P. Morgan traded great today. And I think Karen's point, what's the read on the consumer? Like, how is, you know, business activity going? And we're going to get all that by the end of this week.
14:05You know, when I think about it, and Tim just mentioned this, you know, going back to July, August, there was a growth scare. And so this is like a perfect ingredient, in my opinion, where valuations are in stocks here. You know, the concentration of this index. We also have two years that have been powering the secular shift as far as generative AI. If there is a digestion phase, if CapEx starts coming down, if you do not see the use cases for this technology and the return on those investments, then you put that together with the potential for an economy here, but also overseas that is going to start to feel the effect of just dollar yields.
14:41And then the last thing is the deflation in China. I don't know if that's fixed this year. And I think that's the sort of thing, if that is exported around the world or at least in the emerging world, that's going to weigh on our U.S. multinationals. I think one thing to come out of the banks will be consumer strength. Yes. And I think that we've had this brief sell-off in some discretionary names that I think is an interesting opportunity. Let's get to an earnings alert on KB Home. Shares are jumping after hours on top line and bottom line beats. CNBC's Diana Olek's got more. Diana. Well, Melissa, the big concern here was mortgage rates, which had dropped to recent low in September.
15:14At the time, KB CEO Jeff Metzger said in the previous earnings release that Q4 demand was coming in strong, but rates shot up after that. Apparently, it didn't matter. KB still saw net new orders up 40 percent year over year in Q4. In this release, he said buyers continued to demonstrate a desire for homeownership and housing market conditions improved relative to last year, despite ongoing mortgage interest rate headwinds. Now, the average selling price was even up 3 percent. Gross profit margin increase ever so slightly. KB's average price is right around$500 ,000. So kind of in the middle for new builds, higher than Lenar and D.R.
15:50Horton, lower than Pulte and Taylor Morrison. Home deliveries were up 17 percent year over year. Melissa, I just want to note, I was just listening to the conference call before I wired up and Metzger was saying there that they were seeing a soft start to this quarter, to Q1 of this year. And that's likely due to mortgage rates. He said that he hopes to make it up in the upcoming spring season. All right, Diana, thank you, Diana Olick. That's assuming mortgage rates come down. But if we're here higher for longer, who knows? Scott, what do you make of this point? So, I mean, this was an eighty nine dollar and 70 cent stock a couple months ago, traded almost in a straight line down to where we bottomed out at today.
16:27I think this is a bit of a relief rally. But I'll say again, if you think interest rates are going higher, which I want to be clear, I do. And if the unemployment rate will go higher, which I also do, I think the home builders are a hard buy right now. I take the other side of that respectfully in that we talked about this a number of times, this phenomenon of all of these sort of stranded homes that aren't on the market yet because people's mortgages are too cheap. That, to me, is a bigger threat to home builders, and this environment is good for them. And so I kind of like this space. All right.
16:58Coming up, keep your friends close and your rivals even closer. why Cleveland Cliffs and Nucor may be coming together to make a bid for U.S. Steel and the likelihood that deal gets done. We're continuing to monitor the devastation from the deadly wildfires in California. The latest on the damage is firefighters brace for more dangerous winds. Don't go anywhere. Fast Money's back in two. This is Fast Money with Melissa Lee right here on CNBC.
17:33Welcome back to Fast Money. Firefighting efforts continue in Southern California as dangerous winds and dry weather counter efforts to contain the deadly wildfires in the region. At least 24 people have died and evacuation orders have extended to 92 ,000 L.A. residents. Wells Fargo Securities estimates insured losses of about$30 billion as of this afternoon. Per more on the damages, let's bring in Contessa Brewer, who is there in the midst of it. Contessa.
18:03Yeah, I'm in the Pacific Palisades this evening, Melissa. And we've also seen a massive jump in the estimate on economic losses from AccuWeather. It went from on the high end range of$150 billion to this afternoon,$275 billion. And when you're out here and you see the damage in these neighborhoods, you're just looking at house by house on every street. And to me, it just seems apocalyptic. recovery.lacounty.gov gives homeowners who have still been forced to evacuate some confirmation that maybe their home is gone or by miracle maybe it's still standing. But this website is far from updated. The insurers have said right now they're relying on aerial imagery to go overhead and try to get a sense of where their policies may come into play.
18:54Many of the homeowners in this neighborhood would have bought coverage through California's last resort insurer, the fair plan that we were talking about, Melissa. Today, it sent out a notice saying it's way too soon to put a dollar figure on its expected claims, that it's too soon to say whether it will have to tap other funding sources, which basically means make all the other insurers pay even if they haven't been collecting premiums on these neighborhoods. And it warned it operates on a cash in cash out basis when paying those claims. As I've previously reported, it doesn't have a lot of cash on hand.
19:29So that could mean a delay in getting money into the hands of the people who held those policies. And as of right now, we've seen red flag warnings in effect. Those Santa Ana winds returning, they're expected to pick up and be very strong tomorrow. And this is a neighborhood, a town, a city, really, that is on edge. Melissa? And Contessa, in terms of the fair plan and what it has in reserves, how does that compare to what is now the estimated insured losses of about 30 billion?
20:02Well, remember, we were talking about Pacific Palisades and how as of last year and, you know, we're months behind on updated numbers, but it had some six billion dollars in exposure in the Pacific Palisades. Now, that doesn't mean$6 billion worth of homes that have burned, because as I said, there are some that are still standing. But it had hundreds of millions of dollars statewide in reserves. So how that plays out when there's just so much damage. Melissa, I have not seen damage like this since I covered the aftermath of Hurricane Katrina, and I have never seen it from a fire, ever. Wow. Contessa, thank you.
20:44Contessa Brewer bringing us the latest from California. How should we start thinking about this? I mean, the economic, the impact to lives, which means economic impact, is almost unfathomable at this point, Guy. Yeah, and remember what we're tasked to do. So I don't think any of us want to be, you know, deemed or looked at it being insensitive. That's not the case at all. But in terms of the show and the purview, if California was a country, depending on the day, it needed to be the fifth or sixth largest economy in the world for perspective. So you look what's going on there and you start to connect the dots and say almost by definition, this is going to create a bit of a slowdown.
21:20I mean, it's horrific. And Contessa just said it really well. But in terms of the economic impact, I think the market's going to start to come to grips with it soon. Yeah. Insurers didn't go down today, but that doesn't mean that they bounced in any fashion off of the losses that they saw yesterday. There are a lot of questions here in terms of the insurance market, how this is structured and why there can be such vast, you know, tracks of homes that can be left to the last insurer, you know, basically. Well, and if you look at, again, as Guy's saying, this is this is just trying to assess the insurance market and not in any way comment on the devastation because it's been extraordinary.
21:59And if you look at the the insurance ETF, KIE, for example, what gives you some sense and it runs across, you know, not just property casualty, but a number of other different dynamics. You can see that this was already off about 15 percent coming into this. And we had not only the the tornadoes in the hurricane season that was devastating also on the East Coast and the Caribbean. But but what's what's really clear here is that a lot of these insurance companies were already assessing risks well before this. And that, in fact, as we know, both in terms of they priced premiums significantly higher over the last couple of years coming into this, in some sense, their risk management teams were were hard at work.
22:38And I know that, again, this is a very controversial area, but a lot of these folks were already cut loose. And that's part of the horror here. I mean, a whole middle class of people have seen essentially their life savings in their homes wiped out. There is a lot more fast money to come. Here's what's coming up next. Foe's forging ahead. Unlikely partners coming together to make a bid for U.S. Steel as the deal with Nippon hangs in the balance. What it all means for the U.S. industrial giant. Plus, a huge day for health care as some big pharma names make even bigger stock moves. The sounds and sights from J.P.
23:16Morgan's Health Care Conference. Ahead. You're watching Fast Money, live from the NASDAQ market site in Times Square. We're back right after this.
Read the full transcript
23:31Welcome back to Fast Money. A new deal for U.S. Steel could be in the works. Sources telling our David Faber that Cleveland Cliffs and Nucor are partnering for an offer for the company after the White House blocked Nippon Steel's takeover bid earlier this month. The offer is set to be in the high$30 share range, with Cleveland Cliffs set to complete the purchase in cash, later spinning off the Big River Steel unit to Nucor. This is an interesting development. Two U.S. companies coming together. Sounds like the deal could happen then. Well, it's clear that Cliffs could not have done this by themselves.
24:01And that's why they found a partner with a much better balance sheet, because Cliffs has had a tough time even refurbishing a lot of their own stock. But this has been about Nippon Steel coming in and actually spending money on infrastructure, maybe$6.6 billion, maybe more, keeping people employed. So is it better that two U.S. companies are coming together here? I don't think so. But ultimately about for shareholders where that bid was. And I think it's above 40. I think there's sort of there's still a deal in place, a valid deal in place. And both parties still want to pursue that deal. And both parties still want to pursue that.
24:35So I'm unclear how. First of all, I don't think they could come up. I mean, maybe they could. I think it's unlikely when they talk about a high 30s deal to come up with as much. So I think that, I mean, they can try, but I think we're for a couple of months. I think there's still no clarity here. Yeah. What do you think, Todd? The timing is interesting. I mean, it's, again, it seems to me, though, somebody got a phone call saying, hey, we have to make this happen. Figure it out, you know, Cleveland Cliffs, Nucor, because the optics around this are bad. And I think that's probably what's going on.
25:08Quite frankly, I don't think either of these companies are probably thrilled with the idea, but I think something happens. Along the way, though, it's not going to be a straight line to 40. I mean, there's going to be a day where headlines come out and it's back to 32. And I think that's the environment that U.S. deals in for a little bit. By the way, you hope it's not going to be with Cliff's stock, by the way. I mean, that's a stock that's trading essentially at two-year lows, even near five-year lows. So, again, this is not a company that has a lot of resources and a share price to use as currency.
25:34We have some very exciting news to share about a big event coming for all you diehard Fast Money fans. Today, we are announcing what we are calling Fast Money Live. It's an event that will take place here at the NASDAQ on February 27th. It is your chance to see the show in real life in Times Square at the NASDAQ market site. After the show, you'll stay for a Q &A session with me and all the traders on the desk tonight. You'll raise a glass with them at an exclusive cocktail hour. Plus, you'll be able to visit the Fast Money set and take pictures at our desk on your way out. We'll also give you a special commemorative memento only available to folks attending this event, and you'll get a six-month subscription to CNBC Pro.
26:15Tickets are limited. There's only 100 of them. Talk about a market squeeze. Go to that QR code you see on the screen or go to cnbcevents.com slash fast money for more information. These guys will be on their best behavior, I hope, that night. No, absolutely not. So what about your behavior, Mel? I'm always on my best behavior. So first of all, we've done live events before, and they are some of the best events we've ever done. And we enjoy this as much as the crowd does. So I'm psyched. I'm thinking of taking off scanning the QR code, although I have no idea, and become the NOLANCE member. But people say quickly, how can we be part of the show?
26:52We so want to hang out with you guys and gals. Here's your opportunity on a silver platter. And I promise you it's going to be a lot of fun because the stuff that goes on in the breaks and after the show is worth the price of admission. What happens when this gets to StubHub and these prices actually triple in the aftermarket? In the secondary market? Who knows? Not a lot of supply out there. You've got to go now and buy your own tickets before the prices get jacked up. All right, coming up, major moves in pharma and biotech at J.P. Morgan's healthcare conference is underway. The M &A heating up that space and the company is kicking the weight loss drug competition into even higher gear.
27:26All that when Fast Money returns. Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money podcast. We're back right after this.
27:47Welcome back to Fast Money. Stocks mixed to kick off the week, the Dow jumping more than 350 points, the S &P notching a small gain, but the Nasdaq posting a loss down about four-tenths of a percent, now on a four-day losing streak. Chipotle lower again today. That stock hasn't seen a positive day in 2025 yet. It is now down seven days in a row. It's worst start to the year ever. Shares of some Medicare Advantage players jumping today. The Centers for Medicare and Medicaid Services planning to hike payments to the plans by an average of more than 4 percent next year. We saw gains across the board in this space, including in Elevance, which is a holding of yours, Karen.
28:21Yes, but generally for the space, I mean, this was a positive surprise when they are not used to positive surprises. So that was really good. Also, I mean, the whole space has been beaten down. So I think it's a little bit of maybe there's life there. Some more big moves as the JPMorgan Healthcare Conference sets off a flurry of announcements. Moderna, for one, sinking 17 percent after slashing 2025 revenue guidance by a billion dollars. The stock now back at Lowe's last seen in the early days of the pandemic. Shares of neurological drug maker intracellular surging another 34 percent after Johnson & Johnson agreed to acquire the company for$14.6 billion.
28:56That would be the biggest biopharma deal in almost two years per fact set. Anne Gilead fractionally higher after inking a partnership with Denmark's Leopharma to develop a small molecule pill treating inflammatory diseases. Angelica Peebles joins us now from the conference in San Francisco, where she's also been speaking with leaders in the obesity space. Angelica. Hey, Mel, that's right. And this year, it's not just about weight loss anymore. We talked to two up-and-comers in the space about how the appetite is already changing. And Structure Therapeutic CEO Ray Stevens sees pills as one way to reach millions more people than you can with injectables.
29:33There's this obsession right now with numbers. You know, everybody keeps trying to get the biggest number. And I don't think that's the right place where people should be focusing on. It's really about the patient experience. So I think first, obviously, you have to have efficacy. You have to have weight loss. But tolerability is just as important. You know, if you have a drug that people can't tolerate, they're not going to take it. So we look at tolerability. And then there's a third category that we think is really important, and that's accessibility. And Zeeland Pharma CEO Adam Steensberg says that his vision of a standalone amylin drug is resonating with prospective pharma partners.
30:10If you consider to get into this space, do you want to get into a space where you already have two giants who are dominating within a category of GLP-1-based therapies, or would you rather invest in what looks to be, you can say, a standalone new category with the potential to be a foundation of therapy? So it's super exciting to come in and lead in a new category rather than compete in something that is that established as the current one-based therapies. Both Structure and Zealand are out there looking for partners to bring their drugs to the market, so we'll have to see exactly what they're able to come up with, Mel.
30:41In terms of what analysts are saying are likely the likely partners for these two, Angelica, what are some of the names? You know, at this point, we don't have exact names and, you know, we try to ask, but we don't have, you know, exact ones that are on their target list. But you think of some of the companies that are out there that, you know, haven't gotten into the space but haven't totally ruled it out. Think of Merck, for example. They went out and did a smaller deal. And then you have a company like Novartis. We'll actually have Boss on tomorrow. We can ask him about that. Where, you know, they're not saying that they're out of it.
31:10But, again, they don't want to be in this, you know, obesity 1.0. They're already looking at what's the next thing. All right. Angelica, thank you. Angelica Peoples at a very busy JPMorgan Healthcare Conference. I think the point that Ray Stevens is making about the experience, it has to be effective. But, I mean, if it's going to be 23%, you know, on an injectable versus a 20 % on a pill, patients still might offer the 20 % because that's very good, very effective. Even 18%. But it's a lot easier. Well, what's the skew, right? I mean, what are people willing to sacrifice in order to do the – For ease.
31:46And the stock's going to tell the story. I'll say this. Angelica had a great interview this morning early with Daniel O'Day from Gilead, Georgetown's Daniel O'Day, by the way, telling a great story. I mean, they were the victim of their own success for a long time. But now making acquisitions, making investments, you know, I think Gilead looks really interesting here. You know, this Moderna is such a sad story. And when you think about today's losses, it's going back to like five-year lows, to your point. And, you know, this is a company that actually has a lot of cash. They are just losing so much money.
32:13I think they're going to do a little over the$3 billion in revenue this year, and they're losing more than$3 billion in net income. So you say to yourself, how much longer is that cash going to stick around? I don't know what their IP is worth or anything like that. When you're losing that much money that quickly, it's just a sad story. $16 billion in cash. They lose about$1 billion every quarter. They've already cut back. They've announced more cost cutting. They cut back on R &D, which is probably not where you want to hear a company like that cutting back on. Right. Right. Just remember, though, in the depths of COVID, the stock traded up near 500, I think.
32:48And I think Van Selle actually, insiders did a very good job of selling stock, which, I mean, I know it was sort of unexpected windfall of crazy amount. But, God, the fortunes of this trading. So I wouldn't, I still wouldn't touch it here. Doesn't matter the trade there. And this is what's, Dan's bringing up a great point. I was looking at that today, too. $13 billion in Markup after this move and roughly$9 billion in cash or short-term receivables. But that money's going fast. And again, you look even at the money that Pfizer threw, almost$30 billion to kind of take the next step after COVID.
33:25Moderna doesn't even have that. So be careful. Be sure to tune in to Mad Money tonight for even more exclusive interviews from the J.P. Morgan Healthcare Conference. Jim is chatting with the CEOs of Medtronic, Boston Scientific, and Bristol Myers. Catch all the interviews top of the hour right here on CNBC. Coming up, new year, new acronyms. Yep, it's time. The traders are laying out their 2025 picks and the words they hope will carry them to Fast Money glory. Tim and Dan, stock picks next. Fast Money is back in tune.
34:02Welcome back to Fast Money. It is time to reveal this year's Fast Money trader acronyms. We have been asking the traders to make an acronym of their trades to watch for the year. First up, Tim, the 2024 acronym, of course, is Blysep. Alibaba, Lyft, the International Dividend ETF, Chevron, Estee Lauder, PayPal. Estee Lauder was the biggest issue, problem there, taking 48%. You ended the year in second to last place. Whoa. A 0.1%. If you left the L out, which you added into the game, you'd be up almost 3%. You'd still be in ninth place. Ninth place? Really? Wow, that's tough. And there's only eight of us.
34:43Nice job there. Which acronym do you have for 2025? All right, so this is banned, okay? This is going to be a super group, much like Toto or Traveling Wilburys, not Toto. But, you know, this is a group of super companies. I mean, this is a dream team to me. These are companies that are all, I think you're not taking a flyer on a company like Lyft or whatnot. that might be great someday. These are all great companies. The question is, are they going to get back to their glory? So Boeing, we know this story over and over again. This is a story where the cash flow is not going to come in 25. But if we get a sniff of it coming in 26, this stock is going to move significantly higher.
35:18AMD, we know where they sit. At least it's a distant second. But when you talk about what's coming in through the pipeline and these guys, and again, we're talking about the MI400 and the MI355 is a major catalyst, I think, for a company that really underperformed their peers in 2024. And again, that's part of my rationale in any acronym. I want underperformers. I want companies that I think, again, a little bit of move higher takes them a lot higher. The N is Nike, five-year lows. We know a new CEO. We know it's not going to be fixed overnight. This is best of breed at a time when I think the valuation is starting to make some sense, and I think there's a turnaround coming.
35:50D is Diageo. Again, we've done this news over the last couple weeks about headlines around alcohol. Tell me, there's no question in a world of spirits companies, this is a blue chip. This is one of the best, trades 25 % to its historical. This is band on the run, guy. It's not band-aid. It's band on the run. Which, by the way, is a great Wings song. Great Wings song. Karen liked. No, actually, you don't like that song. No, I don't like that song. That's unfortunate. Thank you for abiding by the rules, for one. I'm one of the few. I may have come in last place for the last five years, but I tell you what, I mean, I play by the rules every time.
36:22All right, let's get to Dan here. 2024's acronym was ZEBRA. You ended in last place. Down 2 % for the year. Zoom, Electronic Arts, Alibaba, Rivian, Applied Materials. Rivian was the only negative name, seeking more than 43%. You're going to keep on betting on a couple of these. You've got some of these rolling over to 2025. Tim said the band is a bunch of great companies. This is a bunch of crap companies. I want to be really clear. This is a game, right? It's a game. The biggest percentage moves in the year. So I'm just playing a game here. So mine is Gen AI. And if you think that this trade has some legs, It's going to take all the crap with it eventually.
36:58So maybe that's this year in 2025. Global Foundry is ugly redheaded stepchild. Whoa, whoa. You can't do that. Really? Well, you just did. There's no redheads that were hurt in this acronym. But Taiwan Semi obviously is the leader there. EA, I think this is a company that's going to really, you know, really integrate generative AI technology into their offering. It's in the game. NXPI, this is a company, a semi-company that has not done particularly well. It's in the industrial space. They're talking about how they're going to use this technology. And then AMAT, I'm sticking with this one here a little bit because this is trading near 52-week lows.
37:33It's a reasonable valuation. And again, if we're going to see the build out of these data centers, that means there's going to be more chips making. And those are going to be the main ones. And then lastly, Intel. I don't really need to say anything here. Ultimately, maybe they'll get something right and this thing starts to work. But again, it's a game. Let's see. Most of these are at 52-week lows. Sounds like he's already kind of like coming up with excuses. What am I going to do? Like, this is the acronym game, man. I just call it a game. I just call it a game. I mean, you'd be kind of a moron if you picked five stocks that are at all time highs.
38:01When people come watch our show live and actually come, we're going to talk acronyms. We're going to sit. We're going to go through your exciting new one. Well, I have a great one this year. That's a tease. Okay, well, I sort of, I totally get what you're doing, which is what I did with the stock draft, which for me is just a shameless plug for Breonna Stewart, great player in the Liberty, but which was go big, go levered, go crappy, and hope for the best. In the acronym, though, I feel like what's a portfolio that could work, not what's a, you know, you could end up with zero. So am I off in the understanding of it?
38:36Just as long as you play it the right way, Karen. Exactly. That's the most important thing, which I know already she has not done. That's another team. But she's allowed. That's right. A special dispensation coming up. The headlines that had Macy's and Howard Hughes heading in very different directions and how you should play the pop and drop. More Fast Money in two.
39:01Welcome back to Fast Money. Shares of Macy's plunging on a weekend holiday shopping forecast. The company is saying it expects net sales for the fourth quarter to be near or below the low end of its previous guidance range. Comp store sales so far this quarter just about flat. The company also announcing the closure of over 60 more stores. Time to check out of this one, Guy. No, I actually think it's time to maybe go through the front door. It traded two times normal volume. It's the lowest we've seen in quite some time. I mean, I don't think that that's necessarily the story. There are other stories around this.
39:31And I do think at some point maybe somebody steps up to the plate. So I wouldn't be running too far from Macy's here. It all depends on where you think this valuation is based upon this guy. because based upon the business they've had for the last year, this is a really cheap company. If you think about also the real estate assets and you think about the private equity interest, I think it's an option worth having. I'd love, by the way, to see what guy would go by if he walked into Mesa. We've been to Mesa. This seems like a parade of mis-execution here. How does private equity buy this with a$4 billion market cap and nearly$6 billion in debt?
40:04Well, I don't know. I always find the shrinking problematic, right? Oh, of course. Of the store footprint, that is. It is inexpensive, though, and the balance sheet has been cleaned up a lot. That's in the plus column. I mean, look, Nordstrom's doing it. Maybe there's a market now. All right. From a drop to a pop, take the shares of Howard Hughes. The stock's soaring nearly 10 percent on news that Bill Ackman is offering to take the company private for 85 bucks a share. That's an 18 percent premium to Friday's close. In a letter to the board, Ackman said his Pershing Square Capital would create a new entity that would merge with a real estate developer.
40:39where Pershing already owns roughly about 38 percent or so of the company. He wants to create a Berkshire Hathaway, he says. I thought that was kind of interesting, Karen, that notion. It is kind of interesting. I mean, you know, he's been in this for a long, long time. He's had some enormous hits. That structure would take a lot. He's allowing people to roll in to be with him if they want to. That's sort of interesting. I haven't bought it, though. What do you think of it? I think it's an interesting thought by him. I mean, this gives him an opportunity. I don't want to say a shell, but in a vehicle to sort of build something.
41:11He's still young enough to do it. So I don't know if you have to run out and buy the stock, but I do think it's an interesting play by him. Berkshire or this new entity? Well, I think we have to go apples and oranges here, as I'm sure would be implying. But I think Berkshire. And I think if you look at a year where the energy assets in Berkshire really kind of underperformed in some level, I actually think it's a year where energy will outperform. And I think some of this is a function of valuations, free cash flow, some of the acquisitions and layering deeper into these trades is what he's been doing.
41:42I like that. Up next, final trades.
41:49Another reminder, do not forget to sign up for Fast Money Live, an exclusive chance to see the show in person here at the Nasdaq Market site on February 27th, including a Q &A session with me, the traders, an exclusive cocktail hour, six months of CNBC Pro, and much more. Tickets are limited. Click on the QR code you can see on your screen or go to cnbcevents.com slash fast money for more information. We are hearing that some people are having trouble with the long. There is a technical issue. Please try again. Tickets are on sale. Time for the final trade. Let's go around the horn. Tim. Yeah, much like the Fast Money event, band is going to be rocking this year, And I think this is the story.
42:27Look at those names. Boom. Dan? Yeah, Gen A.I. wouldn't buy it. It's a game here. But I do think it's going to be important from a sentiment standpoint. If these stocks start to work, we're going to be in a full-on mania. Karen? Yes. A &F. Gigantic sell-off on what I think was really not news that would warrant that. So I actually bought some. You know, it was day one. In Savannah, Georgia, Barbara DeHaven never misses a show celebrating her birthday. Happy birthday. Happy birthday. Gilead? Thank you for watching Fast Mad Money starts right now.
43:35Thank you.
From the publisher
Some of the most popular names in the market seeing some major moves. How the recent drops in Nvidia, Tesla, and Bitcoin fare from here, and how banks are setting up ahead of earnings season. Plus The prognosis on the health care space, as the industry’s top execs convene at the JPMorgan conference in San Francisco. How our traders are handling the moves in the space’s biggest names.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
